Tailored COVID-19 Testing Support Plan for Francophone African Born Immigrants
NCT ID: NCT05805163
Last Updated: 2023-04-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
100 participants
INTERVENTIONAL
2023-09-30
2024-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
COVID-19 Quick Start - Test and Treat in Africa
NCT06360783
Evaluation of the Integration of Ag-RDTs for COVID-19 in MNCH, HIV and TB Services in Cameroon and Kenya
NCT05498727
Interrupting HIV and TB Stigma in the Household in Uganda
NCT05124665
INTEGrating Ag-RDTs for COVID-19 in MNCH,HIV and TB Services in Cameroon and Kenya
NCT05382130
Two-way Texting (2wT) to Improve Antiretroviral (ART) Patient Retention in Malawi
NCT05531448
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SCREENING
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control
Participants will be mailed a standard COVID-19 home-based test kit.
Standard COVID-19 home-based test kit
Standard COVID-19 home-based test kit
Intervention
Participants will be mailed a standard COVID-19 home-based test plus the FABI culturally sensitive COVID-19 educational pamphlet.
FABI tailored COVID-19 testing pamphlet
FABI adapted COVID-19 educational pamphlet
Standard COVID-19 home-based test kit
Standard COVID-19 home-based test kit
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
FABI tailored COVID-19 testing pamphlet
FABI adapted COVID-19 educational pamphlet
Standard COVID-19 home-based test kit
Standard COVID-19 home-based test kit
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Exclusion Criteria
18 Years
99 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institutes of Health (NIH)
NIH
Texas Woman's University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
R0704
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
FY2023-241
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.